Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.

TitleInhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Publication TypeJournal Article
Year of Publication2002
AuthorsCheng S, Brzostek S, Lee SR, Hollenberg AN, Balk SP
JournalMol Endocrinol
Volume16
Issue7
Pagination1492-501
Date Published2002 Jul
ISSN0888-8809
KeywordsAmino Acid Sequence, Animals, Binding Sites, Cells, Cultured, Dihydrotestosterone, Histone Deacetylases, Humans, Mammals, Molecular Sequence Data, Mutation, Nuclear Proteins, Nuclear Receptor Co-Repressor 1, Receptors, Androgen, Repressor Proteins, Transcription, Genetic, Two-Hybrid System Techniques
Abstract

Nuclear receptor corepressor (NCoR) mediates transcriptional repression by unliganded nuclear receptors and certain steroid hormone receptors (SHRs) bound to nonphysiological antagonists, but has not been found to regulate SHRs bound to their natural ligands. This report demonstrates that NCoR interacts directly with the androgen receptor (AR) and represses dihydrotestosterone-stimulated AR transcriptional activity. The NCoR C terminus, containing the receptor interacting domains, was necessary for repression, which was ablated by mutations in the corepressor nuclear receptor (CoRNR) boxes. In contrast, the NCoR N terminus, containing domains that can recruit histone deacetylases, was not necessary for repression. Binding studies in vitro with a series of glutathione-S-transferase-NCoR and -AR fusion proteins demonstrated a direct interaction that was similarly dependent upon the NCoR corepressor nuclear receptor boxes and AR ligand binding domain and was independent of ligand and helix 12 in the AR ligand binding domain. This NCoR-AR interaction was further demonstrated in mammalian two-hybrid assays and by coimmunoprecipitation of the endogenous proteins from a prostate cancer cell line. Finally, AR transcriptional activity could be enhanced in vivo by sequestration of endogenous NCoR with unliganded thyroid hormone receptor. These results demonstrate that AR, in contrast to other SHRs, is regulated by NCoR and suggest the possibility of developing selective AR modulators that enhance this interaction.

DOI10.1210/mend.16.7.0870
Alternate JournalMol Endocrinol
PubMed ID12089345
Grant ListR01-CA65647 / CA / NCI NIH HHS / United States
R01-DK56123 / DK / NIDDK NIH HHS / United States
T32-CA81156 / CA / NCI NIH HHS / United States
Related Faculty: 
Sabrina Racine-Brzostek, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700